Details for Patent: RE37838
✉ Email this page to a colleague
Summary for Patent: RE37838
Title: | Composition for contraception |
Abstract: | A combination product for oral contraception is disclosed comprising an estrogen selected from 2.0 to 6.0 mg of 17.beta.-estradiol and 0.020 mg of ethinylestradiol; and a gestagen selected from .[.0.25 to 0.30 mg of.]. drospirenone and .[.0.1 to 0.2 mg of.]. cyproterone acetate, followed by 5 or 4 pill-free or sugar pill days. |
Inventor(s): | Spona; Jurgen (Vienna, AT), Dusterberg; Bernd (Berlin, DE), Ludicke; Frank (Geneva, CH) |
Assignee: | Schering Aktiengesellschaft (DE) |
Application Number: | 09/504,084 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent RE37838 |
Patent Claim Types: see list of patent claims | Composition; |
Drugs Protected by US Patent RE37838
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: RE37838
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Germany | 4344462 | Dec 22, 1993 |
International Family Members for US Patent RE37838
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 344038 | ⤷ Try a Trial | |||
Canada | 2179728 | ⤷ Try a Trial | |||
China | 100377713 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |